Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cell adhesion inhibitors described by Kyowa Hakko

March 5, 1998

Vitamin D analogues with promising profile from Leo

March 3, 1998

Connetics' NDA for betamethasone mousse accepted by FDA

Feb. 27, 1998

Strengthened safety labeling for Accutane

Feb. 26, 1998

Safety and efficacy of tazarotene gel demonstrated in psoriasis

Feb. 26, 1998

Tazorac launched in Canada

Feb. 19, 1998

HGS's KGF-2 enters clinical testing

Feb. 13, 1998

Promising results with AlloDerm reported

Feb. 10, 1998

Celtrix and Genzyme expand collaboration

Feb. 10, 1998

Psovascar enters phase I/II for psoriasis

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...